Session 4: Special situation I: Signet Ring Cell Cancer
Chairs: Eric Van Cutsem (Belgium), Radka Obermannova (Czech Republic)
- Heike Grabsch, The Netherlands: Signet ring cell carcinoma in the stomach: histopathological definitions and response to therapy assessment – the urgent need for an international consensus
- Stefan Seewald, Switzerland: Endoscopic approach to signet ring cell cancer
- Antoine Adenis, France: Is there a role for neoadjuvant or adjuvant chemotherapy or radiochemotherapy in signet ring cell cancer?
permission for all webcast uploads except discussion pending